Effect of Higher-Dose Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial

The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators, Susanna Naggie
doi: https://doi.org/10.1101/2023.09.12.23295424

Article usage

Article usage: September 2023 to February 2025

AbstractFullPdf
Sep 20237219191
Oct 20231651145
Nov 2023103635
Dec 202339118
Jan 202458019
Feb 202456717
Mar 202445417
Apr 202443516
May 202447420
Jun 202444323
Jul 202450322
Aug 202440422
Sep 202435318
Oct 202438223
Nov 202421317
Dec 202427021
Jan 202531624
Feb 202523718
Back to top
Posted September 13, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Effect of Higher-Dose Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial
The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators, Susanna Naggie
medRxiv 2023.09.12.23295424; doi: https://doi.org/10.1101/2023.09.12.23295424
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area